• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/12

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

12 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

Epidemiology of AF

- affects 5-10% of people over the age of 65yrs

Common causes of AF

- IHD


- rheumatic heart disease


- thyrotoxicosis


- HTN

4

Cardiac causes of AF

- HTN


- CCF


- CAD


- MI


- cardiomyopathy


- valvular heart disease: including RF


- WPW syndrome


- myocarditis


- pericarditis


- sick sinus syndrome


- cardiac surgery


- genetic predisposition

12

Systemic causes of AF

- thyrotoxicosis


- phaechromocytoma


- pulmonary disease: PE, pneumonia, COPD


- symptathetic stimulation: exercise, adrenergic agents


- parasympathetic stimulation: vagally-induced, post-prandial


- alcohol


- caffeine


- smoking


- recreational drugs


- idiopathic

10

Types of AF

- first detected
- paroxysmal
- persistent
- permanent

4

Symptoms of AF

- asymptomatic


- palpitations


- dyspnoea


- faintness

4

Signs of AF

- irregularly irregular pulse


- pulse deficit: difference between pulse & heart sound


- sign of LVF

3

Rhythm control in AF

Anticoagulate for 3wks before hand, unless AF has been present for < 2days


- electrical: DC cardioversion


- pharmacological: flacanide (no heart disease), amiodarone (heart disease)


- other: catheter ablation of automaticity foci, Maze procedure, pacemaker

3

Rate control in AF

Increase AV node refractoriness (used in older patients, or failure of rhythm control)


- digoxin


- beta blockers


- Ca channel blockers: verapamil, diltiazem

3

Anticoagulation in AF
- target INR

CHA2DS2-VASC score (CHF, HRN, Age >75yrs, DM, Stroke/TIA, vascular disease, Age 65-75yrs, Sex category e.g. female) of more than 2


- INR: 2-3

Bleeding risk in AF

HAS-BLED (HTN, Abnormal liver/renal fx, Stroke, Bleeding disorder/prior bleeding event, Labile INR, Elderly > 65yrs, Drug/alcohol use) score of > 3 signifies a high risk of bleeding, proceed with caution

DOACs


- MOA

- dabigatran: direct thrombin inhibitor


- apixaban: factor Xa inhibitor


- edoxaban: factor Xa inhibitor


- riveroxaban: factor Xa inhibitor

4